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Abstract  
Purpose: Low recruitment of adolescents and young adults in cancer clinical trials is 
widely reported and may be linked to limited improvements in survival. Research to 
date does not adequately explain all underlying reasons for poor trial accrual. This 
paper reports health professional perceptions of communicating with adolescents and 
young adults with bone sarcoma about clinical trial participation.  
 
Methods:  This study used narrative inquiry. Findings are reported from thematic 
analysis of in-depth interviews with eighteen multi-disciplinary health professionals 
working in a supra-regional bone and soft tissue sarcoma centre.  
 
Results: Participants described professional expertise, the development of specialist 
knowledge and skills, and strategies used to develop trusting relationships with 
adolescents and young adults with bone sarcoma. These factors were perceived to 
facilitate communication about clinical trial participation. Emergent themes were: 
having credibility through expertise of the team; developing specialist communication 
skills through reflection on practice; having inclusive approaches to education and 
training about clinical trials; individual communication styles used to form trusting 
relationships; using a patient-centred approach to connect with adolescents and young 
adults; creating time needed to form trusting relationships; and effective team 
working.  
 
Conclusions: We aligned findings of this study with characteristics of patient-
physician trust and provide a basis for transferable recommendations. Our findings 
can be used to inform the development of age-specific, specialist communication 
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skills and highlight health professional education needs about clinical trials. 
Additional research is needed to explore which elements of team working optimise 
improved clinical trial participation, in what contexts, and why. 
 
Keywords: Adolescents; Young Adults; Cancer; Narrative Inquiry; Clinical Trials; 
Patient-Professional Communication 
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Introduction 
Bone sarcomas (primary bone cancers) have a peak incidence during adolescence and 
young adulthood [1, 2] and a five-year survival rate of 50 – 60% [3]. Survival 
improvements over the last thirty years have been modest and may be related, in part, 
to fewer adolescents and young adults (AYA) participating in clinical trials than other 
age groups [4-6].  
 
Similar to other countries, England has set a target that at least half of AYA with 
cancer are entered into trials by 2025 [7], with the aim of improving patient outcomes. 
There is some way to go to achieve this target for sarcoma, because only one in four 
British adolescents with soft tissue sarcoma were included in a recent European study 
[8].  
 
Potential barriers to recruiting AYA to clinical trials include: developmental 
considerations [9]; AYA and parent perspectives [10]; health care system factors [11]; 
and research design issues [12]. Successful recruitment is also thought to be 
dependent on the acceptability of the trial, which is influenced by AYAs’ perceptions 
of the trial [6, 12]. Since a person is presumed to have consent from the age of 16 in 
England [13], there is a need to understand more fully the relationship between AYA 
patients and health professionals, which can influence decisions about participating in 
a research study [14].  
 
We report here additional findings from our study that sought to gather perceptions 
from AYA and health professionals regarding participation in two bone cancer trials 
[12]. In this paper we explore professional expertise, specialist knowledge and skills 
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development, and strategies described by the health professionals for communicating 
with AYAs about participating in two large, collaborative, international, randomised 
bone sarcoma clinical trials for newly diagnosed patients: EURAMOS-1 (E-1) [15] 
and EUROEWING-99 (EE-99) [16]. These trials were chosen to understand what 
influences AYA trial participation, because deficits in AYA accrual to E-1 and EE-99 
have been observed [17], and osteosarcoma and Ewing sarcoma have peak incidence 
in AYA [1, 2] with little improvement in survival over the past two decades.  
 
Methods 
Study design 
Narrative interviews were undertaken with health professionals and AYAs aged 15 – 
24 with bone cancer using an interpretative, qualitative approach [18], which explored 
the ‘whats’ and ‘hows’ of participants narratives from their experience [19].  The age 
range of the AYA recruited to the study was determined by age criteria for AYA 
specialist care used in England [20]. In this paper we will focus on the health 
professionals in the study; the methods and findings of interviews with the AYAs are 
reported elsewhere [12]. 
 
Study setting and sample 
This was a single centre study conducted at a supra-regional bone and soft tissue 
sarcoma centre that conducts clinical trials and hosts one of the largest principal 
treatment centres for young people in England. We used purposeful sampling [21] to 
invite twenty-nine health professionals representative of this service configuration, 
and who treated and cared for AYAs who were eligible to be recruited to the E-1 or 
EE-99 clinical trials. Eighteen health professionals agreed to participate. This 
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included: nine who were directly involved in recruiting AYAs to the E-1 or EE-99 
trials (medical oncologists, oncology trainee doctors, clinical nurse specialists [CNS] 
and research nurses); and nine participants who treated and cared for AYAs on these 
two clinical trials (orthopaedic surgeons, chemotherapy nurses, ambulatory care and 
oncology ward managers, and clinical trial pharmacists). 
 
Ethical approval and informed consent 
Ethical approval was obtained from a National Health Service research ethics 
committee (study reference: 11/LO/0523). We e-mailed invitations with participant 
information packs to health professionals inviting them to participate in an interview, 
and followed the e-mail with a telephone invitation. We obtained written and 
informed consent from potential participants. We assured anonymity and 
confidentiality, and participants were informed they could withdraw from the study at 
any time without giving a reason. 
 
Data collection 
The research team included experienced qualitative health researchers. Semi-
structured narrative interviews were conducted by AB and took place with the 
professionals in a setting of their choice. An illustration of the open questions used for 
interviewing health professionals is shown in Table 1. Participants were asked to 
describe their perceptions about, experiences of, and role in, recruiting, treating or 
caring for AYAs invited to, and enrolled in, E-1 and EE-99 clinical trials.  Interviews 
lasted an average of 40 minutes and, with permission, were digitally recorded.  
 
Data analysis 
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Interviews were transcribed and the transcripts were analysed by memoing, coding 
and constantly comparing codes to identify emergent themes, using an interpretative 
approach similar to that described by Charmaz [22]. All transcripts were read and 
coded by AB and SP. To validate the coding process, a sample of interviews were 
independently conducted by two experienced health care qualitative researchers, VL 
and FG. VL independently coded all health professional interview transcripts. 
Initially, thematic analysis of interview data from health professional participants was 
conducted separately from analysis of the AYA interview data to generate two 
analytical frameworks: an AYA framework and health professional framework [12]. 
SP and VL re-checked coded transcripts by comparing coding of all interviews 
against the analytical frameworks to ensure no findings had been missed and data 
sufficiency had been achieved, which added another level of rigour to the analytical 
process. A combined analytical framework including both AYA and health 
professional data were developed by integrating themes common to both data sets 
(where there was a high level of agreement between coded data) [12]. Themes that 
emerged from coded health professional data that were distinct from those arising 
from the AYA data were re-examined by SP and VL.  
 
Results 
Participants described aspects of professional expertise and specialist knowledge and 
skills development that were perceived as important for effective communication with 
the AYA, as well as strategies used to communicate with AYAs about clinical trial 
participation. 
 
Professional expertise and specialist knowledge and skills development  
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Having credibility through expertise of the team 
Professionals spoke about being part of an experienced team that was ‘used to dealing 
with AYAs’ and working in a centre ‘very driven towards research’. The time in their 
current role ranged from newly appointed to more than 20 years in post; most 
participants had multiple years’ experience of working with AYAs, in cancer services 
and/or cancer clinical trials.  
 
Some health professionals spoke about the team’s experience and nature of the centre 
influencing the perception of the AYA. One health professional said, “Obviously 
because this is a specialist centre, they (the AYA) are just very happy to be 
somewhere where they know they’re getting very good quality treatment.” [Health 
Professional #02 (HP02):p2] The experience and expertise of team members was 
identified as an asset in providing information with sensitivity, “There are some 
people who are very sensitive and very capable at judging what’s enough…And 
experience teaches people that.” [HP13:p5] 
 
Developing specialist communication skills through reflecting on practice of, and 
with, others 
More junior health professionals referred to learning from observing senior 
professionals in practice. “Well for me it was helpful to sit in (on clinical trial and 
consent appointments), and then you learn techniques.” [HP06:p12] ‘Learners’ either 
regarded a senior practitioner as a role model and someone’s practice they aspired to, 
or they ‘learned from the mistakes’ of others and identified behaviours that they 
would not wish to emulate. “It’s very good to have videos of deliberate mistakes, well 
mistakes.  And then the video stays in your head very well.” [HP06:p12] 
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More senior professionals commented on the lack of opportunity to learn from 
observing the practice of peers: “Once you’re a consultant you never, you don’t see 
other people’s practice, and you don’t see other people doing consultations with 
patients.” [HP07:p6] Instead, consultants spoke about receiving feedback from 
nursing colleagues. “I’ve learnt most from getting feedback from clinical nurse 
specialists who say, ‘That went really well,’ or them saying, ‘That didn’t go so well, 
they were shocked to hear this,’ or whatever. That’s what I’ve based, that’s how my 
practice has evolved in the way I give information.” [HP08:p5] 
 
Need for inclusive approaches to education and training about clinical trials 
Systems were in place to provide education and training about the trials to health 
professionals. This training was often as part of the trial initiation process. 
“Sometimes there’s the launch of a new trial, and there’s a formal teaching session 
arranged. […] Sometimes it’s less formal.” [HP13:p2] Professionals who were not 
able to attend formal training sessions described being ‘updated’ by colleagues who 
could attend. Some health professionals also spoke about ongoing training 
opportunities: “There are various different teaching sessions and opportunities 
throughout the pattern of the week.  And yes the staff are encouraged to go to those 
sessions.” [HP13:p3] 
 
However, health professionals not directly involved in trial recruitment felt less well-
informed about trials and had less opportunity to receive education. Health 
professionals identified a lack of knowledge of the trials as an issue: “[If educated] we 
know how the trial works, what the arms mean and all that sort of thing… then we can 
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actually answer questions from the patients…. there’s nothing worse than someone 
being on a trial and even we don’t really know what’s going on, which, you know, has 
happened before.” [HP09:p7] To ensure credibility across the team, health 
professionals thought education and training should be more inclusive and accessible 
to the wider multidisciplinary team. 
 
Individual communication styles used to form trusting relationships 
With the exception of one health professional who thought all professionals would 
probably structure clinical trial consultations in the same way, informed by their trial 
training and shared philosophy of care, most professionals had views that each 
professional had a unique style of communication, and thus conducted consultations 
differently. This created a sense of needing to observe a range of colleagues in 
practice to develop optimal communication skills. “We all have our different ways 
and means of saying things, you know, and we all have our different ways of, you 
know, approaching patients… I don’t know whether that does affect how many 
patients are recruited and how many patients aren’t.  But I’m sure it may do.” 
[HP04:p6]  
 
The level of sensitivity and skill health professionals perceived were needed to 
provide accurate and honest information to AYAs about the E-1 and EE-99 trials 
without causing undue alarm or distress were highlighted. “I’ve certainly seen some 
doctors explain things just amazingly and I’ve seen others kind of be slightly - not 
brash, perhaps is a little bit too harsh, but kind of a bit too kind of straight pointed 
with it, a bit too blunt.” [HP09:p5]  
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Strategies health professionals used to communicate with AYAs about bone 
cancer trial participation 
Using a patient-centred approach to connect with the AYA 
Health professionals talked about strategies to facilitate openness and sharing with the 
AYA, to reinforce the patient-centred philosophy they practiced, and in doing so, 
fostered trust. One method of demonstrating patient-centred care was by asking the 
AYA “if there was anything they wanted to talk about or ask?” [HP02:p7-8]  
Another strategy used by one health professional to demonstrate patient-centredness 
and ‘make them feel comfortable’ was to identify common ground with the AYA. 
“Well every time I’m about to discuss the trial with somebody, I’m trying to relate 
with them and I mean I’ll try to find something in common […] or I’m trying to find 
something that interests them, so they feel at ease and sort of comfortable chatting to 
me.” [HP06:p5] This might involve honing in on a specific interest, like commenting 
on “something they’re watching or their opinion about a gadget or if they’re wearing a 
football shirt, just to try to relate to them really.” [HP06:p6] 
 
Many health professionals emphasised the need to individualise the approach when 
respecting autonomy of the AYA and meeting the needs of family members. Health 
professionals acknowledged the need for family-centred care, communicating with 
parents (particularly of younger adolescents) and partners (of older adolescents and 
young adults), but they reported taking care to maintain patient-centred 
communication. “We are quite careful about talking to parents without the patient 
there.  We do talk to them, but more specific questions about outcomes and more 
personal questions, we’ll be very careful to make sure that the patient was involved in 
those.” [HP10:p5] Sometimes it was a legal requirement to involve parents in decision 
making: “For the younger ones, the parents have to consent as well.  So one has to 
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make sure that the parents are on the same level as the patient, because they have to 
put their name to it as well… if they’re under 16, but one tries to talk to the patient 
first rather than the parents.” [HP03:p9] Health professionals also highlighted that for 
some AYAs, partners needed to be considered: “It’s not just the young person 
themselves, it may be ………..partner, that maybe have questions?” [HP04:p3]  
 
Creating time needed to form trusting relationships 
In addition to referring to a lack of time to interact with the AYA [11], health 
professionals described some strategies they used to ‘make time’. One strategy was to 
meet the young person as soon as it was convenient to do so. “I think the earlier you 
can meet them and develop some sort of rapport; I mean it does help (in discussing 
clinical trial participation).” [HP14:p5] Other professionals talked about being 
committed to working a longer day if needed, “We’re all prepared to do longer 
consultations and repeat consultations, even though that’s going to make our clinics 
longer and bigger.” [HP07:p7] Making time to work around the needs of AYAs 
demonstrated person-centred care: “You need to go when they are not in pain. Or if 
they are about to have lunch, if they’re having guests…Or just woken up. Simple 
things like that. …That’s why you need plenty of time…But respecting the individual 
and sort of make time, even if it’s after hours, before hours, I think it helps.” 
[HP06:p5]. 
 
One health professional described their ideal approach: “In a perfect world, what it 
would be is, you meet them the first time, you go through all the illness and you’d say 
to them, you know, ‘There’s a clinical trial, I really want to talk with you about it, but 
why don’t you go and have some tests and then I’ll come back and meet you and talk 
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to you again,’ and then you can, then you have a much greater amount of time to 
focus purely on the clinical trial aspect. So basically I do need three meetings with 
them… More often than not one has two.” [HP03:p6] 
 
Effective team working to facilitate the development of a trusting patient-professional 
relationship 
Health professionals coherently articulated their own roles and involvement in the 
recruitment, treatment and care of AYAs participating in the bone sarcoma clinical 
trials. They were conscious that having discussions about participation in clinical 
trials often within two weeks of diagnosis, and sometimes at the same time as sharing 
their cancer diagnosis, was overwhelming for the AYA.  
 
Doctors recognised the challenges of having difficult conversations with AYAs within 
the clinic environment and the importance of team work, for example seeking support 
and ‘reassurance’ from nurses: “If you’ve had a clinical nurse specialist in with you 
and it’s been particularly difficult, then you’ll, afterwards you’ll say, ‘That was 
difficult.’ […] You might reflect for a few minutes, but usually there’s another patient 
to see.” [HP07:p10] 
 
For AYAs with a new diagnosis of bone cancer there was an additional challenge of 
meeting a range of different health professionals, which could detract from 
developing trusting patient-professional relationships. “I think they almost meet too 
many people at the beginning and there can be a rather overwhelming number of new 
faces and new roles.” [HP2:p9] One strategy was to delegate core communication to 
one or two members of the team, often the consultant and the CNS. 
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Health professionals talked about the CNS having a pivotal role in clinical trial 
participation: “With the input of the CNS, sometimes if it’s not appropriate to meet 
me, the CNS will hand out information sheets and go through what’s required rather 
than think, ‘Oh someone else to see,’ and they’ll follow that up and keep me in the 
loop and everything.  So it is about working as a team.” [HP18:p9] Similarly, CNSs 
utilised team members as a source of information about the clinical trials.  
 
Discussion and Conclusion 
Discussion 
Our findings identify the perceived importance of professional expertise and 
development to support specialist communication about AYA clinical trial 
participation, and expand on strategies that go some way towards detailing how 
clinical trials can be ‘effectively presented’ as part of the pathway to enrolment [23].  
 
A recurrent finding was that health professionals attempted to form trusting patient-
professional relationships to aid communication with AYAs, while recognising the 
importance of the family and the need for family-centred care. Trust is widely 
recognised as being central to the doctor-patient relationship [24] and discussing 
clinical trial participation with AYA [12]. It is also described as a foundation for 
AYAs and health professionals to establish clear communication [25] and a virtue of 
Good Clinical Practice (GCP) [26].  
 
We aligned the emergent themes presented here with four main characteristics of 
‘physician-patient’ interaction associated with trust [27] (see Figure 1). Three 
16 
 
characteristics are based on the patient’s perception of the physician including: 
perceived technical competence; being straightforward and ‘telling the truth’ 
(honesty); and perceived patient-centred communication. The fourth characteristic, 
the organisation of clinical services, includes allocation of time and continuity of care 
needed for the establishment of patient-physician relationships. 
 
Having the specialist technical competence to form trusting patient-professional 
relationships was perceived as highly important by the participants in our study, 
which Sawyer and colleagues [28] identify as an indicator of adolescent-friendly 
health care.  Health professionals described developing specialist knowledge and 
skills through experiential learning. In some instances this provided a sense of inter-
professional and interdisciplinary support and encouraged reflection on their own 
practice. In particular, consultants talked about developing their communication skills 
based on feedback from nursing colleagues working alongside them in consultations. 
 
Fallowfield [29] recommends that health professionals learn advanced communication 
skills by predominantly experiential training methods rather than apprenticeship 
models of learning [29, 30]. In addition to developing advanced communication skills, 
health professionals working in AYA services require age-specific communication 
skills [31].  
 
Adolescence and young adulthood is a life-stage transition [32, 33] characterised by 
cognitive, emotional and social development. Having a cancer diagnosis during 
adolescence and young adulthood intensifies the biopsychosocial challenges of these 
developmental stages and requires specialised care [9].  For young adults, cancer 
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causes a shift in their life narrative, resulting in desire to stay in control, retain 
independence and autonomy, and retain their former identity [34]. This range of 
complex, individual, age-specific needs means experiential learning opportunities 
need to be created within the context of specialist AYA services. 
 
Patient-centred care is an essential element of the recruitment process [26] and was 
identified as one of five ‘top competencies’ needed to provide specialised AYA care 
[35]. Key communication skills that aligned to these competencies were: listening to 
AYAs’ concerns; talking about difficult issues; using familiar terminology while 
maintaining professional boundaries; telling AYA about all aspects of their disease; 
and acting as an advocate [35]. In our study, health professionals used patient-centred 
communication to facilitate the development of a trusting and open relationship to 
help put the AYA at ease; one strategy described was to attempt to make a connection 
with the AYA by finding a common topic of conversation. 
 
Using more familiar language might be regarded as ‘small talk’; however strategies 
that actively engage AYA in conversations is thought to help in their understanding of 
the complexity of the trial, the risk-benefits and burden, and what it will mean to them 
if they do, or do not, consent to enrol [26]. Bora and Kim [36] also recommend using 
“humanistic engagements” such as ‘small talk’ to promote open and engaging 
communication with AYA. 
 
The health professionals in this study described discussing trial participation with 
parents and other family members using a family-centred approach [37]; however 
they took care to maintain patient-centred care. Sometimes inclusion of parents was 
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necessary, as the parent was required to provide consent if the adolescent was under 
the age of sixteen; sometimes this was at the request of the AYA. It was evident that 
managing competing information needs of AYA and their family was sometimes 
difficult, highlighting a need for AYA-specific communication skills. Detailed 
findings about family-centred care and patient autonomy from this study have been 
previously reported and discussed [12]. 
 
The organisation of clinical services in this study was based on a multidisciplinary 
team approach to cancer care, which is widely advocated [7, 38]. Sharing both 
learning, and roles and responsibilities in communicating with AYAs about clinical 
trial participation, reinforced the notion of effective team work. For example, CNSs 
worked closely with other members of the multi-disciplinary team, particularly 
consultants and research nurses. French and Stavropoulou [39] also reported that close 
team working between the CNS and research nurses was beneficial for trial 
recruitment [39], where the CNS can facilitate information exchange between 
research nurses and patients as part of their key worker role in coordinating treatment 
and care [40-42].  
Receiving education and training about the trials was valued and helped the 
professionals in this study feel more credible. Health professionals thought education 
and training should be more inclusive and accessible to the wider multidisciplinary 
team, for example at trial initiation. However, not all health professionals involved in 
the treatment and care of AYAs with bone sarcoma received GCP training, and only 
some health professionals involved in recruitment received additional age-specific or 
advanced communication skills training. In the UK, senior medical professionals and 
senior cancer nurses, such as CNSs, have access to advanced communication skills 
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training, but these training opportunities are not widely available and AYA age-
specific training opportunities are limited [43]. 
Professionals also suggested methods to support AYA communication skill 
development such as: learning from mistakes, watching videos of scenarios where 
things fell short of good quality care; and practicing communication skills in a ‘safe’ 
learning environment. We propose that all professionals working with AYAs with 
cancer should have access to age-specific communication skills training, which 
includes interdisciplinary, experiential learning. Furthermore, supporting health 
professionals to develop age-specific communication skills should be seen as a 
priority if current AYA trial recruitment targets are to be met. Since completing this 
study a simple strategy introduced at the centre hosting this research, is for 
professionals attending a monthly sarcoma trial operational team meeting to routinely 
share experience of, and reflect on, discussions with AYAs who have subsequently 
declined to consent to participate in a clinical trial.  
 
Strengths and limitations of the study 
This study was conducted at a single study site, which represents a familiar model of 
caring for AYAs with bone sarcoma in the UK and other countries with similar 
models of AYA care. This study recruited health professionals treating and caring for 
AYAs recruited to two complex, first-line, bone sarcoma-specific trials, which limits 
the transferability of all findings. Some findings, however, resonate with literature 
from other areas of cancer practice, which suggests transferability. We included a 
range of professional roles in this study and although not all were directly involved in 
trial recruitment, the participants gave insight into the experiences of health 
professionals involved in the treatment and care of trial eligible AYA across care 
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settings. Although participants were not invited to comment on coded transcripts, 
study findings have been shared at the study site. Exploring the dynamic of working 
across teams highlights the necessity of effective multidisciplinary team working in 
providing trustworthy and consistent information to AYAs about clinical trial 
participation. 
Conclusion 
This study provides insight into the perceived importance of professional expertise 
and development, and strategies for communicating with AYAs about bone cancer 
trial participation. An underpinning concept was the need to build trusting patient-
professional relationships. Our findings can be used to inform the development of 
specialist knowledge and skills needed to communicate with AYAs with bone cancer 
and their families about clinical trial participation. Research exploring which elements 
of team work most effectively support clinical trial participation and why, is 
warranted. 
  
21 
 
Acknowledgements 
We thank all healthcare professionals who gave up their time to participate in this 
study. We also thank the Bone Cancer Research Trust for funding this study; and the 
National Institute for Health Research, Teenage Cancer Trust and Oxford Brookes 
University for financially supporting the authors of this study. Thanks also to 
Professor Helen Dawes, Oxford Brookes University, for reviewing drafts of this 
manuscript. 
 
Statement of confidentiality 
We confirm all personal identifiers have been removed or disguised so the persons 
described are not identifiable and cannot be identified through the details of the story. 
 
Conflict of Interest 
The authors declare no potential conflicts of interests with respect to the research, 
authorship or publication of this article. This study was funded by the Bone Cancer 
Research Trust grant (Grant Number BCRT 21/10) and supported by researchers at 
the National Institute for Health Research Biomedical Research Centre University 
College London Hospitals, and Oxford Brookes University. Lorna Fern is funded by 
the Teenage Cancer Trust. The authors have full control of all primary data, which 
can be reviewed by Supportive Care in Cancer at the journal’s request.   
22 
 
References 
1. Bleyer A, Barr R. & Ries L.A.G. (2006) Cancer Epidemiology in Older Adolescents 
and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 
1975-2000. NIH, Bethesda, MA, USA. 
 
2. Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, Bolton RD et al. 
(2017) ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma 
in Adults and Bone Sarcoma. A critical review. Critical Reviews in 
Oncology/Hematology 110:94-105. doi: 
http://dx.doi.org/10.1016/j.critrevonc.2016.12.002 
 
3. Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S and Strauss SJ 
(2012) Incidence and survival of malignant bone sarcomas in England 1979-2007. Int 
J Cancer 131:E508-17. doi: 10.1002/ijc.26426 
 
4. Bleyer A (2005) The adolescent and young adult gap in cancer care and outcome. 
Current Problems in Pediatric and Adolescent Health Care 35:182-217.  
 
5. Birch JM, Pang D, Alston RD, Rowan S, Geraci M, Moran A and Eden TOB (2008) 
Survival from cancer in teenagers and young adults in England, 1979-2003. British 
Journal of Cancer 99:830-835. doi: 10.1038/sj.bjc.6604460 
 
6. Fern LA, Lewandowski JA, Coxon KM and Whelan J (2014) Available, accessible, 
aware, appropriate, and acceptable: a strategy to improve participation of teenagers 
23 
 
and young adults in cancer trials. Lancet Oncol 15:e341-50. doi: 10.1016/s1470-
2045(14)70113-5 
 
7. Independent Cancer Taskforce (2015) Achieving World Class Cancer Outcomes, A 
Strategy for England 2015 – 2020.  
 
8. Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D et 
al. (2017) Access to clinical trials for adolescents with soft tissue sarcomas: 
Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) 
protocols. Pediatr Blood Cancer 64. doi: 10.1002/pbc.26348 
 
9. Docherty SL, Kayle M, Maslow GR and Santacroce SJ (2015) The Adolescent and 
Young Adult with Cancer: A Developmental Life Course Perspective. Semin Oncol 
Nurs 31:186-96. doi: 10.1016/j.soncn.2015.05.006 
 
10. Read K, Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Pentz RD, Barfield 
RC et al. (2009) Decision-making by adolescents and parents of children with cancer 
regarding health research participation. Pediatrics 124:959-65. doi: peds.2008-2878 
[pii]10.1542/peds.2008-2878 [doi] 
 
11. Bleyer A (2007) Adolescent and young adult (AYA) oncology: the first A. Pediatr 
Hematol Oncol 24:325-36.  
 
24 
 
12. Pearce S, Brownsdon A, Fern L, Gibson F, Whelan J and Lavender V (2016) The 
perceptions of teenagers, young adults and professionals in the participation of bone 
cancer clinical trials. Eur J Cancer Care (Engl). doi: 10.1111/ecc.12476 
 
13. NHS Choices (2014) Consent toTreatment - Children and Young People at: 
https://www.nhs.uk/conditions/consent-to-treatment/children/ (accessed 09.05.18) 
 
14. Broome ME, Richards DJ and Hall JM (2001) Children in research: the experience 
of ill children and adolescents. Journal of Family Nursing 7:32-49.  
 
15. Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M et al. 
(2015) EURAMOS-1, an international randomised study for osteosarcoma: results 
from pre-randomisation treatment(). Annals of Oncology 26:407-414. doi: 
10.1093/annonc/mdu526 
 
16. EUROpean_Ewing_tumour_Working_Initiative_of_National_Groups (2017) 
Combination chemotherapy with or without peripheral stem cell transplantation, 
radiation therapy, and/or surgery in treating patients with Ewing's sarcoma.  ISRCTN 
Registry at: http://www.isrctn.com/ISRCTN61438620 (accessed 09.05.18) 
 
17. Fern L, Davies S, Eden T, Feltbower R, Grant R, Hawkins M, Lewis I et al. (2008) 
Rates of inclusion of teenagers and young adults in England into National Cancer 
Research Network clinical trials: report from the National Cancer Research Institute 
(NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer 
99:1967-74.  
25 
 
 
18. Schwandt TA (2000) Three epistemiological stances for qualitative inquiry: 
interpretivism, hermeneutics, and social construction. In: Denzin NK, Lincoln, Y.S. 
(ed) Handbook of qualitative research, 2nd edn. Sage Publications, Thousand Oaks 
pp. 189- 213 
 
19. Squire C (2008) From experience-centred to socio-culturally narrative approaches 
to narrative. In: Andrews MS SCTM (ed) Doing Narrative Research,  Sage, London, 
UK pp. 41–64 
 
20. National Institute for Health and Clinical Excellence (2005) Guidance on Cancer 
Services: Improving Outcomes in Children and Young People with Cancer, The 
Manual.  NICE, London pp. 8 
 
21. Patton QM (2002) Qualitative research and evaluation methods. Sage, Thousand 
Oaks, CA. 
 
22. Charmaz K (2000) Grounded theory objectivist and constructivist methods. In: 
Lincoln DNa (ed) Handbook of qualitative research, 2nd edn. Sage Publications, 
Thousand Oaks pp. 509-536 
 
23. Freyer DR and Seibel NL (2015) The Clinical Trials Gap for Adolescents and 
Young Adults with Cancer: Recent Progress and Conceptual Framework for 
Continued Research. Current Pediatric Reports 3:137–145 doi: DOI 10.1007/s40124-
015-0075-y24. Thom DH, Hall MA and Pawlson LG (2004) Measuring patients' trust 
26 
 
in physicians when assessing quality of care. Health Aff (Millwood) 23:124-32. doi: 
10.1377/hlthaff.23.4.124 
 
25. Bahrami M, Namnabati M, Mokarian F, Oujian P and Arbon P (2017) 
Information-sharing challenges between adolescents with cancer, their parents and 
health care providers: a qualitative study. Support Care Cancer 25:1587-1596. doi: 
10.1007/s00520-016-3561-z 
 
26. Nuffield Council on Bioethics (2015) Children and Clinical Research: Ethical 
issues. Nuffield Council on Bioethics, London, UK pp. 131 - 175 
 
27. Hillen MA, de Haes HC and Smets EM (2011) Cancer patients' trust in their 
physician-a review. Psychooncology 20:227-41. doi: 10.1002/pon.1745 
 
28. Sawyer SM, Ambresin AE, Bennett KE and Patton GC (2014) A measurement 
framework for quality health care for adolescents in hospital. J Adolesc Health 
55:484-90. doi: 10.1016/j.jadohealth.2014.01.023 
 
29. Fallowfield L (2005) Learning how to communicate in cancer settings. Support 
Care Cancer 13:349-50. doi: 10.1007/s00520-004-0765-4 
 
30. Fallowfield L, Langridge C and Jenkins V (2014) Communication skills training 
for breast cancer teams talking about trials. Breast 23:193-7. doi: 
10.1016/j.breast.2013.11.009 
27 
 
31. Essig S, Steiner C, Kuehni CE, Weber H and Kiss A (2016) Improving 
Communication in Adolescent Cancer Care: A Multiperspective Study. Pediatr Blood 
Cancer 63:1423-30. doi: 10.1002/pbc.26012 
 
32. Erikson EH (1995) Childhood and Society. Vintage Books, London. 
 
33. Havighurst R (1972) Developmental tasks and education. David McKay Co Inc., 
New York. 
 
34. Soanes L and Gibson F (2018) Protecting an adult identity: A grounded theory of 
supportive care for young adults recently diagnosed with cancer. Int J Nurs Stud 
81:40-48. doi: 10.1016/j.ijnurstu.2018.01.010 
 
35. Taylor RM, Feltbower RG, Aslam N, Raine R, Whelan JS and Gibson F (2016) 
Modified international e-Delphi survey to define healthcare professional 
competencies for working with teenagers and young adults with cancer. BMJ Open 
6:e011361. doi: 10.1136/bmjopen-2016-011361 
 
36. Bora K and White K (2017) How can health professionals enhance interpersonal 
communication with adolescents and young adults to improve health care outcomes?: 
Systematic literature review. International Journal of Adolescence and Youth. doi: 
DOI: 10.1080/02673843.2017.1330696 
 
28 
 
37. Corlett J and Twycross A (2006) Negotiation of parental roles within family-
centred care: a review of the research. J Clin Nurs 15:1308-16. doi: 10.1111/j.1365-
2702.2006.01407.x 
 
38. Borras JM, Albreht T, Audisio R, Briers E, Casali P, Esperou H, Grube B et al. 
(2014) Policy statement on multidisciplinary cancer care. Eur J Cancer 50:475-80. 
doi: 10.1016/j.ejca.2013.11.012 
 
39. French C and Stavropoulou C (2016) Specialist nurses' perceptions of inviting 
patients to participate in clinical research studies: a qualitative descriptive study of 
barriers and facilitators. BMC Med Res Methodol 16:96. doi: 10.1186/s12874-016-
0204-5 
 
40. Ling J, McCabe K, Brent S and Crosland A (2013) Key workers in cancer care: 
patient and staff attitudes and implications for role development in cancer services. 
Eur J Cancer Care (Engl) 22:691-8. doi: 10.1111/ecc.12079 
 
41. Martins A, Aldiss S and Gibson F (2016) Specialist nurse key worker in children's 
cancer care: Professionals' perspectives on the core characteristics of the role. Eur J 
Oncol Nurs 24:70-78. doi: 10.1016/j.ejon.2016.08.009 
 
42. National Cancer Action Team (2010) Quality in Nursing Excellence in Cancer 
Care:The Contribution of the Clinical Nurse Specialist.  Department of Health, 
London, UK  
29 
 
43. Coad J, Smith J, Pontin D and Gibson F (2018) Consult, Negotiate, and Involve: 
Evaluation of an Advanced Communication Skills Program for Health Care 
Professionals. J Pediatr Oncol Nurs:1043454218765136. doi: 
10.1177/1043454218765136 
  
30 
 
Table 1. Question guide for health professional interviews  
Can you tell me a little bit about your role (in the care of patients with 
bone cancers/ soft tissue tumours)? 
What involvement do you have with the bone sarcoma clinical trials?  
How long have you been involved with these trials/ caring for people 
undergoing these trials? 
What do you understand about clinical trials in general? 
What are your thoughts about treating patients on clinical trials?  
What do you think are the specific issues around recruiting young people 
(15-24 year olds) with cancer to clinical trials? 
What is your understanding of the bone cancer specific trials, Euramos-1 
and EE-99? 
What do you perceive are factors that influence participation in Euramos-1 
and EE-99 for AYA?  
Can you tell me about how AYA patients are recruited to the bone sarcoma 
clinical trials? 
Can you tell me what you discuss when talking to young people or their 
parents, about clinical trial participation? 
What support is there for patients making decisions about entering these 
clinical trials? 
How do you feel about discussing randomisation? 
What sorts of things do you think (would) help support young people 
through the clinical trial? 
 What do you think might support the professionals involved in this 
process? 
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Fig. 1 Alignment between emergent themes and the characteristics of patient-
physician interaction associated with trust  
 
Emergent themes from health professional interviews were compared with criteria 
that constituted the characteristics of patient-physician interaction associated with 
trust [27]. Themes were aligned to characteristics where there was significant 
similarity between each.  
 The themes having credibility through expertise and developing specialist 
communication skills through reflection, which were about professional 
expertise and specialist knowledge and skills development, aligned to the 
characteristic of technical competence  
 Organisation of clinical services aligned to the professional expertise and the 
development of specialist knowledge and skills theme inclusive education 
and training. Two themes about strategies also aligned to the characteristic 
organisation of clinical services: creating time and effective team working  
 The strategy of using a patient-centred approach to connect with the AYA 
and professional expertise and specialist knowledge and skills theme 
individual communication styles aligned to both patient-centred 
communication and honesty, indicated by a dashed line in the diagram 
 
 
